Global University Venturing

Juno Therapeutics increases its cancer treating T-cell research by acquiring Harvard spinout Abvitro, which focuses on diseases resistant to the immune system.

The pharmaceutical firm's Lilly Asia Ventures unit is co-investing in the T-cell technology developer with University of Pennsylvania.

The DNA sequencing technology developer raises $9.25m from Utah University's Arup Laboratories and others to further develop its product and increase sales and marketing.

A fund co-created by Shanghai Jiao Ton University's investment unit backs Jerry Education's $40m round to open more schools and develop an online platform.

Lodo Therapeutics has been launched by investment firm Accelerator Corporation with series A capital from investors including AbbVie, Eli Lilly, Wuxi PharmaTech, Pfizer, IBM and Johnson & Johnson.

The news roundup for the week ending 15 January 2016.

We take a look at the results from the annual Global University Venturing survey conducted in the run up to the holidays last year.

University of Tokyo Edge Capital backs fingerprint payment system creator Liquid to help it develop its product for possible use at the 2020 Tokyo Olympics.

A weekly update on interesting deals

India and the US make progress on the Joint Declaration of Intent signed a year ago by forging a partnership between Duke University and the Indian Institute of Technology Gandhinagar Campus.